Severe Neurological Manifestations of Multisystem Inflammatory Syndrome in Adults (MIS-A)

Article Sidebar

PDF Download
Published Jul 31, 2022
DOI: https://doi.org/10.18103/mra.v10i7.2908

Downloads

Download data is not yet available.

Submit your own article

Register as an author to reserve your spot in the next issue of the Medical Research Archives.

Author Registration

Join the Society

The European Society of Medicine is more than a professional association. We are a community. Our members work in countries across the globe, yet are united by a common goal: to promote health and health equity, around the world.

Join Europe’s leading medical society and discover the many advantages of membership, including free article publication.

Membership

Main Article Content

Boby Varkey Maramattom, MD,DM, FRCP, FRCPE, FICCN
Dept of Neurology, Aster Medcity, Kochi, Kerala, India, 682023

Abstract

Introduction; Multi-system inflammatory syndrome (MIS) is a para infectious or post infectious extra-pulmonary complication of COVID-19. Neurological complications are better described in children with multi-system inflammatory syndrome (MIS) in children (MIS-C). There is a paucity of literature about severe neurological manifestations of multi-system inflammatory syndrome in adults (MIS-A).


Methods; Over a 22-month period, from June 2020 to December 2021, over 3450 COVID patients were admitted to our institution including 900 patients in the medical and COVID ICUs. Ten patients (1.1%) presented to us with MIS-A with severe neurological manifestations.


Results; Severe neurological manifestations included transverse myelitis, COVID encephalitis, acute encephalopathy, status epilepticus and rhabdomyolytic myopathy. Our cohort had a high morbidity and mortality rate.


Conclusions; Most patients with MIS-A had severe neurological involvement and a poor outcome.

Keywords: Multisystem inflammatory syndrome in adults, MIS-A, neurological, MIS-A, India, COVID reinfection, MIS-A

Article Details

How to Cite
MARAMATTOM, Boby Varkey. Severe Neurological Manifestations of Multisystem Inflammatory Syndrome in Adults (MIS-A). Medical Research Archives, [S.l.], v. 10, n. 7, july 2022. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/2908>. Date accessed: 24 nov. 2024. doi: https://doi.org/10.18103/mra.v10i7.2908.
ABNT APA BibTeX CBE EndNote - EndNote format (Macintosh & Windows) MLA ProCite - RIS format (Macintosh & Windows) RefWorks Reference Manager - RIS format (Windows only) Turabian
Issue
Vol 10 No 7 (2022): Vol.10 Issue 7 July 2022
Section
Research Articles

The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.

 

References

1. Davogustto GE, Clark DE, Hardison E, et al. Characteristics Associated With Multisystem Inflammatory Syndrome Among Adults With SARS-CoV-2 Infection. JAMA Netw Open. 2021;4(5). doi:10.1001/jamanetworkopen.2021.10323
2. Multisystem Inflammatory Syndrome in Adults (MIS-A) Case Definition Information for Healthcare Providers. Accessed July 9, 2021. https://www.cdc.gov/mis/mis-a/hcp.html
3. Abel D, Shen MY, Abid Z, et al. Encephalopathy and bilateral thalamic lesions in a child with MIS-C associated with COVID-19. Neurology. 2020;95(16). doi:10.1212/WNL.0000000000010652
4. Mavrogeni SI, Kolovou G, Tsirimpis V, Kafetzis D, Tsolas G, Fotis L. The importance of heart and brain imaging in children and adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C). Rheumatol Int. 2021;41(6). doi:10.1007/s00296-021-04845-z
5. Nepal G, Shrestha GS, Rehrig JH, et al. Neurological Manifestations of COVID-19 Associated Multi-system Inflammatory Syndrome in Children: A Systematic Review and Meta-analysis. J Nepal Health Res Counc. 2021;19(1). doi:10.33314/jnhrc.v19i1.3410
6. Morris SB, Schwartz NG, Patel P, et al. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection — United Kingdom and United States, March–August 2020. MMWR Morb Mortal Wkly Rep. 2020;69(40). doi:10.15585/mmwr.mm6940e1
7. Henderson LA, Canna SW, Friedman KG, et al. No Title. Arthritis Rheumatol.
8. Gu SX, Tyagi T, Jain K, et al. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nat Rev Cardiol. 2021;18(3). doi:10.1038/s41569-020-00469-1
9. Roncati L, Nasillo V, Lusenti B, Riva G. Signals of Th2 immune response from COVID-19 patients requiring intensive care. Ann Hematol. 2020;99(6). doi:10.1007/s00277-020-04066-7
10. Qureshi AI, Baskett WI, Huang W, et al. Acute Ischemic Stroke and COVID-19. Stroke. 2021;52(3). doi:10.1161/STROKEAHA.120.031786
11. Spence JD, de Freitas GR, Pettigrew LC, et al. Mechanisms of Stroke in COVID-19. Cerebrovasc Dis. 2020;49(4). doi:10.1159/000509581
12. Shi Z, de Vries HJ, Vlaar APJ, et al. Diaphragm Pathology in Critically Ill Patients With COVID-19 and Postmortem Findings From 3 Medical Centers. JAMA Intern Med. 2021;181(1). doi:10.1001/jamainternmed.2020.6278
13. Maramattom BV, Wijdicks EFM. Acute neuromuscular weakness in the intensive care unit. Crit Care Med. 2006;34(11). doi:10.1097/01.CCM.0000239436.63452.81
14. BV M, S B. Neurological Complications with COVID-19: A Contemporaneous Review. Ann Indian Acad Neurol. 2020;23(4):468-476. doi:10.4103/AIAN.AIAN_596_20
15. Aschman T, Schneider J, Greuel S, et al. Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died. JAMA Neurol. 2021;78(8):948. doi:10.1001/jamaneurol.2021.2004
16. Maramattom BV, Rao T. Cortical unihemispheric brain edema (CUBE) due to a multi-system inflammatory syndrome in adults (MIS-A). Epileptic Disord. 2022;24(3):1-8. doi:10.1684/epd.2022.1429